Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
暂无分享,去创建一个
I. Bruce | D. Gladman | C. Gordon | D. Isenberg | K. Kalunian | O. Nived | M. Petri | J. Sánchez-Guerrero | M. Urowitz | G. Alarcón | S. Bae | V. Farewell | K. Steinsson | M. Khamashta | D. Wallace | G. Ruiz-Irastorza | D. Kamen | M. Inanç | J. Merrill | S. Manzi | R. Ramsey‐Goldman | M. Ramos-Casals | A. Clarke | W. Chatham | P. Fortin | C. Peschken | J. Hanly | Anisur Rahman | R. Vollenhoven | S. Jacobsen | C. Aranow | M. Mackay | J. Romero-Diaz | E. Ginzler | M. Dooley | S. Lim | A. Askanase | Qiuju Li | S. Bernatsky | A. Zoma | C. Theriault | L. Su | A. Jonsen | J. Romero-Díaz | G. Ruiz‐Irastorza
[1] Systemic Lupus Erythematosus Disease Activity Index , 2020, Definitions.
[2] O. Jolobe,et al. Systemic , 2020, Definitions.
[3] E. Morand,et al. Discordance of patient and physician health status concerns in systemic lupus erythematosus , 2018, Lupus.
[4] D. Gladman,et al. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study , 2015, Arthritis & rheumatology.
[5] J. Craig,et al. Experiences and Perspectives of Adults Living With Systemic Lupus Erythematosus: Thematic Synthesis of Qualitative Studies , 2013, Arthritis care & research.
[6] I. Bruce,et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. , 2013, Arthritis and rheumatism.
[7] T. Brady,et al. Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test , 2012, Lupus.
[8] I. Bruce,et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study , 2012, Annals of the rheumatic diseases.
[9] Gerald McGwin,et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.
[10] M. Boaz,et al. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. , 2011, Seminars in arthritis and rheumatism.
[11] I. Bruce,et al. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.
[12] D. Gladman,et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus , 2010, Arthritis care & research.
[13] I. Bruce,et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.
[14] C. Mok,et al. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus , 2009, Scandinavian journal of rheumatology.
[15] C. Granger,et al. Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus. , 2008, Arthritis and rheumatism.
[16] I. Bruce,et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. , 2008, Arthritis and rheumatism.
[17] I. Bruce,et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. , 2008, Arthritis and rheumatism.
[18] I. Bruce,et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.
[19] D. Isenberg,et al. Systemic Lupus International Collaborating Group—onwards and upwards? , 2006, Lupus.
[20] J. Reveille,et al. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. , 2006, Arthritis and rheumatism.
[21] J. Hanly,et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. , 2004, The Journal of rheumatology.
[22] M. Ward. Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. , 2004, Arthritis and rheumatism.
[23] G. Hughes,et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. , 2003, The Journal of rheumatology.
[24] W. Brooks,et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[25] G. Gronseth,et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.
[26] J. Merrill,et al. Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome , 2002, Lupus.
[27] D. Gladman,et al. Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.
[28] A. Auvinen,et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.
[29] J. Peltola,et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus , 2001, Neurology.
[30] J. Merrill,et al. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. , 1999, Thrombosis and haemostasis.
[31] Caroline Gordon,et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.
[32] T. Ng,et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. , 1999, The Journal of rheumatology.
[33] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[34] J. Merrill,et al. High prevalence of antiphospholipid antibodies in patients taking procainamide. , 1997, The Journal of rheumatology.
[35] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.